:
Transfusion (2021)
Major Weight Loss Results In a Phase 2 clinical trial with 338 adults, participants on the highest dose lost an average of 24.2% of their body weight in 48 weeks
Seven additional TRIUMPH-family readouts are expected through the remainder of 2026, including obesity-only (TRIUMPH-1), obesity + diabetes (TRIUMPH-2), obesity + cardiovascular risk (TRIUMPH-3), SELECT-M (obesity in MASH), SLEEP (obstructive sleep apnea), BACK PAIN, and a cardiovascular/renal outcomes readout
Your doctor should create a schedule based on your specific needs rather than a one-size-fits-all plan
Researchers have explored its relationship with angiogenesis, fibroblast activity, collagen organisation and tissue repair processes, making it one of the most frequently discussed peptides in musculoskeletal and sports medicine research